Meghan Stranick

Meghan Stranick has a diverse work experience in the field of Regulatory Affairs. Meghan began their career as a Research Intern at Universiti Teknologi PETRONAS, Malaysia in 2015. In 2016, they became a Mid-Scale Manufacturing Intern at Regeneron Pharmaceuticals, Inc. and then transitioned to the roles of Associate CMC Regulatory Sciences Specialist and Biotech Production Specialist in 2017. In 2019, they joined WuXi Advanced Therapies as a Senior Regulatory Affairs Specialist and Regulatory Affairs Specialist. Currently, they are the Regulatory Affairs Manager at SwanBio Therapeutics since 2021.

Meghan Stranick attended Merion Mercy Academy from 2009 to 2013 and then pursued a Bachelor of Science in Chemical Engineering from Lehigh University from 2013 to 2017.